Loading…
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients
Mone, Pasquale, Varzideh, Fahimeh, Jankauskas, Stanislovas S., Pansini, Antonella, Lombardi, Angela, Frullone, Salvatore, Santulli, Gaetano
Published in Hypertension (Dallas, Tex. 1979) (01.08.2022)
Published in Hypertension (Dallas, Tex. 1979) (01.08.2022)
Get full text
Journal Article
Loading…
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
Wright, Alison K., Carr, Matthew J., Kontopantelis, Evangelos, Leelarathna, Lalantha, Thabit, Hood, Emsley, Richard, Buchan, Iain, Mamas, Mamas A., van Staa, Tjeerd P., Sattar, Naveed, Ashcroft, Darren M., Rutter, Martin K.
Published in Diabetes care (01.04.2022)
Published in Diabetes care (01.04.2022)
Get full text
Journal Article
Loading…
Loading…
Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence
Muller, Dion R. P., Stenvers, Dirk J., Malekzadeh, Arjan, Holleman, Frederik, Painter, Rebecca C., Siegelaar, Sarah E.
Published in Frontiers in endocrinology (Lausanne) (10.10.2023)
Published in Frontiers in endocrinology (Lausanne) (10.10.2023)
Get full text
Journal Article
Loading…
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Cusi, Kenneth, Bril, Fernando, Barb, Diana, Polidori, David, Sha, Sue, Ghosh, Atalanta, Farrell, Kristin, Sunny, Nishanth E., Kalavalapalli, Srilaxmi, Pettus, Jeremy, Ciaraldi, Theodore P., Mudaliar, Sunder, Henry, Robert R.
Published in Diabetes, obesity & metabolism (01.04.2019)
Published in Diabetes, obesity & metabolism (01.04.2019)
Get full text
Journal Article
Loading…
Real-world Evidence of Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Therapy in Adults With Type 1 Diabetes: A European Two-Center Experience
Palanca, Ana, van Nes, Falco, Pardo, Felipe, Ampudia Blasco, F. Javier, Mathieu, Chantal
Published in Diabetes care (01.03.2022)
Published in Diabetes care (01.03.2022)
Get full text
Journal Article
Loading…
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
Liu, Hongyan, Sridhar, Vikas S., Boulet, Jacinthe, Dharia, Atit, Khan, Abid, Lawler, Patrick R., Cherney, David Z.I.
Published in Metabolism, clinical and experimental (01.01.2022)
Published in Metabolism, clinical and experimental (01.01.2022)
Get full text
Journal Article
Loading…
Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
Cheung, Ka Shing, Ng, Ho Yu, Hui, Rex Wan Hin, Lam, Lok Ka, Mak, Lung Yi, Ho, Yuen Chi, Tan, Jing Tong, Chan, Esther W., Seto, Wai Kay, Yuen, Man Fung, Leung, Wai K.
Published in Hepatology (Baltimore, Md.) (01.10.2024)
Published in Hepatology (Baltimore, Md.) (01.10.2024)
Get full text
Journal Article
Loading…
Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Gan, Sushrima, Dawed, Adem Y., Donnelly, Louise A., Nair, Anand T.N., Palmer, Colin N.A., Mohan, Viswanathan, Pearson, Ewan R.
Published in Diabetes care (01.08.2020)
Published in Diabetes care (01.08.2020)
Get full text
Journal Article
Loading…
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Trial
Zanchi, Anne, Burnier, Michel, Muller, Marie‐Eve, Ghajarzadeh‐Wurzner, Arlène, Maillard, Marc, Loncle, Nicolas, Milani, Bastien, Dufour, Nathalie, Bonny, Olivier, Pruijm, Menno
Published in Journal of the American Heart Association (07.07.2020)
Published in Journal of the American Heart Association (07.07.2020)
Get full text
Journal Article
Loading…
Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus
Berg, David D., Moura, Filipe A., Bellavia, Andrea, Scirica, Benjamin M., Wiviott, Stephen D., Bhatt, Deepak L., Raz, Itamar, Bohula, Erin A., Giugliano, Robert P., Park, Jeong-Gun, Feinberg, Mark W., Braunwald, Eugene, Morrow, David A., Sabatine, Marc S.
Published in Journal of the American College of Cardiology (27.06.2023)
Published in Journal of the American College of Cardiology (27.06.2023)
Get full text
Journal Article
Loading…
Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
Gaborit, B., Ancel, P., Abdullah, A. E., Maurice, F., Abdesselam, I., Calen, A., Soghomonian, A., Houssays, M., Varlet, I., Eisinger, M., Lasbleiz, A., Peiretti, F., Bornet, C. E., Lefur, Y., Pini, L., Rapacchi, S., Bernard, M., Resseguier, N., Darmon, P., Kober, F., Dutour, A.
Published in Cardiovascular diabetology (01.03.2021)
Published in Cardiovascular diabetology (01.03.2021)
Get full text
Journal Article
Loading…
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study
Palmiero, Giuseppe, Cesaro, Arturo, Galiero, Raffaele, Loffredo, Giuseppe, Caturano, Alfredo, Vetrano, Erica, Rinaldi, Luca, Salvatore, Teresa, Ruggiero, Roberto, Rosaria Di Palo, Maria, Sardu, Celestino, Marfella, Raffaele, Limongelli, Giuseppe, Calabrò, Paolo, Carlo Sasso, Ferdinando
Published in Diabetes research and clinical practice (01.06.2023)
Published in Diabetes research and clinical practice (01.06.2023)
Get full text
Journal Article
Loading…
Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials
Singh, Awadhesh Kumar, Singh, Ritu
Published in Diabetes & metabolic syndrome clinical research & reviews (01.05.2020)
Published in Diabetes & metabolic syndrome clinical research & reviews (01.05.2020)
Get full text
Journal Article
Loading…
Loading…
Effects of SGLT-2 Inhibitors on Vascular Endothelial Function and Arterial Stiffness in Subjects With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Wei, Ran, Wang, Weihao, Pan, Qi, Guo, Lixin
Published in Frontiers in endocrinology (Lausanne) (16.02.2022)
Published in Frontiers in endocrinology (Lausanne) (16.02.2022)
Get full text
Journal Article
Loading…
Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events
Mannucci, Edoardo, Gallo, Marco, Giaccari, Andrea, Candido, Riccardo, Pintaudi, Basilio, Targher, Giovanni, Monami, Matteo
Published in Diabetes, obesity & metabolism (01.02.2023)
Published in Diabetes, obesity & metabolism (01.02.2023)
Get full text
Journal Article
Loading…
Treatment of type 2 diabetes patients with heart conditions
Aktas, Gulali, Atak Tel, Burcin Meryem, Tel, Ramiz, Balci, Buse
Published in Expert review of endocrinology & metabolism (04.05.2023)
Published in Expert review of endocrinology & metabolism (04.05.2023)
Get more information
Journal Article
Loading…
Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors
Alatrach, Mariam, Laichuthai, Nitchakarn, Martinez, Robert, Agyin, Christina, Ali, Ali Muhammed, Al-Jobori, Hussein, Lavynenko, Olga, Adams, John, Triplitt, Curtis, DeFronzo, Ralph, Cersosimo, Eugenio, Abdul-Ghani, Muhammad
Published in Diabetes (New York, N.Y.) (01.04.2020)
Published in Diabetes (New York, N.Y.) (01.04.2020)
Get full text
Journal Article